Ostro (FKA RxDefine) is a healthcare engagement platform led by CEO Chase Feiger, MD, that provides tools for consumer and HCP engagement. Its renamed product suite includes Ostro Navigate (a 1:1 personalized journey for consumers and HCPs), Ostro Attribute (analytics that connect brand marketing campaigns to clinical outcomes), and Ostro Consult (a telehealth experience connecting patients to clinicians). The company has expanded its target market from a pharmaceutical-focused use case to address pharmaceuticals, medical devices, digital therapeutics, and diagnostics. Ostro intends to use recent funding to expand operations and broaden its business reach. In 2022 the company increased headcount by 50% and grew annual revenue by over 250%. To date it has raised over $55M in total funding.

Total raised

$45M

Funding rounds

1

Latest round

Equity

Latest activity

Dec 2022